Image
27.10.2022
November Menopause Sessions
From Tuesday 1 November, Diabetes UK Northern Ireland will be hosting the first of five sessions discussi...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more